Clin2
NCT07815626Possibly a fitNot yet recruiting

Daily growth hormone injections for children with unexplained short stature

Idiopathic Short Stature (ISS)

Part of Hormones & metabolism clinical trials.

This study tests whether a daily injection of human growth hormone (called Sinotropin AQ) can safely help children with unexplained short stature grow taller. It is for children who are shorter than expected but do not have a known medical reason for their short height.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
240 people
Ages
3 years to 11 years
Study type
Interventional

Who can take part

  • Your child must be a boy aged 3 to under 11 years, or a girl aged 3 to under 10 years, and must not have started puberty.
  • Your child must be significantly shorter than average for their age and sex (height at least 2 standard deviations below the average).
  • Your child must have a normal response to a growth hormone stimulation test (peak growth hormone level of 10.0 ng/mL or more).
  • Your child's bone age (measured by X-ray) must not be more than 1 year older than their actual age.
  • Your child must not have other known causes of short stature (like growth hormone deficiency, Turner syndrome, or being born small for gestational age).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06927310Recruiting· Phase 3
Growth Hormone Injection for Idiopathic Short Stature in Children

This study tests a new growth hormone injection (Inpegsomatropin) to help children with idiopathic short stature (short stature with no known cause) grow taller. It may be an option if your child is very short compared to peers and has not started puberty.

Hefei, Anhui
NCT07450053Not yet recruiting· Phase 1/Phase 2
Growth hormone treatment for children with short stature

This trial is testing an experimental growth hormone treatment for children who are short for their age but otherwise healthy. Participation may help determine if the treatment can safely improve growth.

Wuhan, Hubei
NCT06309979Recruiting
Growth study for children with idiopathic short stature

This study tests whether an investigational drug can help children with idiopathic short stature (short height with no known cause) grow taller. It may be an option for children who are very short for their age and have not responded well to standard growth hormone therapy.

Phoenix, Arizona
NCT06110910Recruiting
Growth hormone study for children with short stature

This study tests if growth hormone can safely help children who are shorter than average for their age and gender. It is for children with certain conditions that cause short stature.

Wuhan, Hubei
NCT06768411Not yet recruiting
Growth hormone dose study for short children

This study tests different doses of a long-acting growth hormone medicine to see which works best for children who are shorter than expected for their age. It may help improve growth in both early and later stages of puberty.

NCT07260500Recruiting· Phase 2
Growth hormone study for short children born small for gestational age

This trial tests a weekly growth hormone injection called PEG-rhGH to see if it helps short children born small for gestational age grow taller. It may be an option if your child has never taken growth hormone before and meets the height and age requirements.

Wuhan, Hubei

Hear when a new Idiopathic Short Stature (ISS) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.